IL1R2 and neoplasm: Furthermore, knockdown of BMI1 or USP15 inhibited the enhanced tumor growth by IL1R2 overexpression in vivo (Figure 4K; Figure S5D, Supporting Information), and also inhibited the BTICs enrichment in the xenograft tumors (Figure 4L).